Cargando…
Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
OBJECTIVES: Haemolytic uraemic syndrome (HUS) following Shiga toxin-producing Escherichia coli (STEC) infection is the the most common cause of acute renal failure among children in the UK. This study explored differential progression from STEC to HUS by social, demographic and clinical risk factors...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936988/ https://www.ncbi.nlm.nih.gov/pubmed/31909217 http://dx.doi.org/10.1136/bmjpo-2019-000465 |
_version_ | 1783483798682337280 |
---|---|
author | Adams, Natalie Byrne, Lisa Rose, Tanith Adak, Bob Jenkins, Claire Charlett, Andre Violato, Mara O'Brien, Sarah Whitehead, Margaret Barr, Benjamin Taylor-Robinson, David Hawker, Jeremy |
author_facet | Adams, Natalie Byrne, Lisa Rose, Tanith Adak, Bob Jenkins, Claire Charlett, Andre Violato, Mara O'Brien, Sarah Whitehead, Margaret Barr, Benjamin Taylor-Robinson, David Hawker, Jeremy |
author_sort | Adams, Natalie |
collection | PubMed |
description | OBJECTIVES: Haemolytic uraemic syndrome (HUS) following Shiga toxin-producing Escherichia coli (STEC) infection is the the most common cause of acute renal failure among children in the UK. This study explored differential progression from STEC to HUS by social, demographic and clinical risk factors. METHODS: We undertook a retrospective cohort study linking two datasets. We extracted data on paediatric STEC and HUS cases identified in the Public Health England National Enhanced Surveillance System for STEC and British Paediatric Surveillance Unit HUS surveillance from 1 October 2011 to 31 October 2014. Using logistic regression, we estimated the odds of HUS progression by risk factors. RESULTS: 1059 paediatric STEC cases were included in the study, of which 207 (19.55%, 95% CI 17% to 22%) developed HUS. In the fully adjusted model, the odds of progression to HUS were highest in those aged 1–4 years (OR 4.93, 95% CI 2.30 to 10.56, compared with 10–15 years), were infected with an Shiga toxin (stx) 2-only strain (OR 5.92, 95% CI 2.49 to 14.10), were prescribed antibiotics (OR 8.46, 95% CI 4.71 to 15.18) and had bloody diarrhoea (OR 3.56, 95% CI 2.04 to 6.24) or vomiting (OR 4.47, 95% CI 2.62 to 7.63), but there was no association with progression to HUS by socioeconomic circumstances or rurality. CONCLUSION: Combining data from an active clinical surveillance system for HUS with the national enhanced STEC surveillance system suggests that 20% of diagnosed paediatric STEC infections in England resulted in HUS. No relationship was found with socioeconomic status or rurality of cases, but differences were demonstrated by age, stx type and presenting symptoms. |
format | Online Article Text |
id | pubmed-6936988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-69369882020-01-06 Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study Adams, Natalie Byrne, Lisa Rose, Tanith Adak, Bob Jenkins, Claire Charlett, Andre Violato, Mara O'Brien, Sarah Whitehead, Margaret Barr, Benjamin Taylor-Robinson, David Hawker, Jeremy BMJ Paediatr Open Epidemiology OBJECTIVES: Haemolytic uraemic syndrome (HUS) following Shiga toxin-producing Escherichia coli (STEC) infection is the the most common cause of acute renal failure among children in the UK. This study explored differential progression from STEC to HUS by social, demographic and clinical risk factors. METHODS: We undertook a retrospective cohort study linking two datasets. We extracted data on paediatric STEC and HUS cases identified in the Public Health England National Enhanced Surveillance System for STEC and British Paediatric Surveillance Unit HUS surveillance from 1 October 2011 to 31 October 2014. Using logistic regression, we estimated the odds of HUS progression by risk factors. RESULTS: 1059 paediatric STEC cases were included in the study, of which 207 (19.55%, 95% CI 17% to 22%) developed HUS. In the fully adjusted model, the odds of progression to HUS were highest in those aged 1–4 years (OR 4.93, 95% CI 2.30 to 10.56, compared with 10–15 years), were infected with an Shiga toxin (stx) 2-only strain (OR 5.92, 95% CI 2.49 to 14.10), were prescribed antibiotics (OR 8.46, 95% CI 4.71 to 15.18) and had bloody diarrhoea (OR 3.56, 95% CI 2.04 to 6.24) or vomiting (OR 4.47, 95% CI 2.62 to 7.63), but there was no association with progression to HUS by socioeconomic circumstances or rurality. CONCLUSION: Combining data from an active clinical surveillance system for HUS with the national enhanced STEC surveillance system suggests that 20% of diagnosed paediatric STEC infections in England resulted in HUS. No relationship was found with socioeconomic status or rurality of cases, but differences were demonstrated by age, stx type and presenting symptoms. BMJ Publishing Group 2019-12-17 /pmc/articles/PMC6936988/ /pubmed/31909217 http://dx.doi.org/10.1136/bmjpo-2019-000465 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology Adams, Natalie Byrne, Lisa Rose, Tanith Adak, Bob Jenkins, Claire Charlett, Andre Violato, Mara O'Brien, Sarah Whitehead, Margaret Barr, Benjamin Taylor-Robinson, David Hawker, Jeremy Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
title | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
title_full | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
title_fullStr | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
title_full_unstemmed | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
title_short | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
title_sort | sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936988/ https://www.ncbi.nlm.nih.gov/pubmed/31909217 http://dx.doi.org/10.1136/bmjpo-2019-000465 |
work_keys_str_mv | AT adamsnatalie sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT byrnelisa sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT rosetanith sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT adakbob sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT jenkinsclaire sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT charlettandre sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT violatomara sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT obriensarah sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT whiteheadmargaret sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT barrbenjamin sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT taylorrobinsondavid sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy AT hawkerjeremy sociodemographicandclinicalriskfactorsforpaediatrictypicalhaemolyticuraemicsyndromeretrospectivecohortstudy |